# US 2010/0164489 A1 · System for Detecting Nanoparticles Using Modulated Surface Plasmon Resonance

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0164489 A1
- Document ID: US20100164489A1
- Status: Published application
- Kind: A1
- Application number: 12/278,655
- Filed: 2007-02-07
- Published: 2010-07-01
- Earliest claimed: 2006-02-08
- Assignees: The University of Toledo
- Inventors: Rosa A. Lukaszew; Xuefei Huang
- Web page: https://patentgrep.com/patent/US20100164489A1

## CPC

- G01N 33/54326: {Magnetic particles}
- G01N 21/554: {detecting the surface plasmon resonance of nanostructured metals, e.g. localised surface plasmon resonance}
- G01N 33/54373: {involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings}
- Y10S 435/808: Optical sensing apparatus
- Y10S 436/805: Optical property
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

A method and system for detecting magnetic nanoparticles include measuring a magneto-optical enhancement of the plasmon absorption in the optical response.

## Claims

### Claim 1

A system for detecting magnetic nanoparticles comprising measuring magneto-optical enhancement of optical plasmon absorption response in one or more nanoparticles.

### Claim 2 (depends on 1)

The system of claim 1, comprising implanting depositing or patterning one or more magnetic metallic nanoparticles, clusters or thin films in a metallic or dielectric matrix to form a modulated surface plasmon resonance material capable of allowing the magnetic metallic nanoparticles or films to exhibit enhanced plasmon-like resonances and magneto-optical properties.

### Claim 3 (depends on 1)

The system of claim 1, comprising a material configured for measuring a magneto-optical enhancement of a plasmon optical response and magneto-optical activity enhanced by surface plasmon resonance.

### Claim 4

A system comprising an array having nanoclusters of magnetic nanoparticles embedded on a metallic or dielectric thin film matrix.

### Claim 5

A system for making magnetic glyco-nanoparticles comprising attaching one or more glycoconjugates to magnetic nanoparticles.

### Claim 6 (depends on 2)

The system of claim 2, comprising functionalizing magnetic nanoparticles with organic molecules comprising using a direct attachment approach.

### Claim 7

A system for detecting magnetic particles, comprising a sensing material having a matrix having implanted, deposited or patterned therein one or more magnetic nanoparticles or thin films, the matrix being capable of allowing the magnetic metallic nanoparticles to exhibit plasmon-like resonances and magneto-optical properties, and having binding nanoparticles deposited on the surface of the sensing material.

### Claim 8 (depends on 7)

The system of claim 7, wherein the binding nanoparticles comprise glyco-nanoparticles.

### Claim 9 (depends on 7)

The system of claim 7, wherein the system further includes binding the glyco-nanoparticles to one or more agents.

### Claim 10 (depends on 7)

The system of claim 7, wherein the implanting or patterning includes one or more of at least partially embedding the magnetic metallic nanoparticles in the matrix, or at least partially coating the magnetic metallic nanoparticles on the matrix.

### Claim 11 (depends on 7)

The system of claim 7, wherein the matrix comprises one or more of a metal, glass or other dielectric substrate.

### Claim 12 (depends on 7)

The system of claim 7, wherein the magnetic nanoparticles in the matrix are configured for use as a magneto-optical sensor.

### Claim 13 (depends on 12)

The system of claim 12, in which the sensor is configured for detecting magnetic glyco-nanoparticles that are capable of binding to one or more agents.

### Claim 14 (depends on 13)

The system of claim 13, in which the sensor is configured for pathogen detection.

### Claim 15 (depends on 1)

The system of claim 1, further including embedding magnetic nanoparticles on a thin film.

### Claim 16 (depends on 1)

The system of claim 1, wherein detecting binding magnetic nanoparticles includes characterizing one or more of surface plasmon resonance (SPR) and magneto-optical (MO) properties of the nanoparticles.

### Claim 17 (depends on 16)

The system of claim 16, wherein the magnetic and MO properties are characterized by:
measuring in reflection geometries using fixed frequency light with variable incidence angle and alternating magnetic field; and,
finding an optimum frequency for observation of a magneto-optical enhanced plasmon-effect using spectral determination of optimal magneto-optical Kerr activity.

### Claim 18 (depends on 17)

The system of claim 17, further including detecting optical plasmon absorption which is enhanced due to magneto-optical activity, wherein one or more of the angular position and amplitude of the plasmon resonance are affected by one or more of a size and shape of a ferromagnetic transition metal inclusion.

### Claim 19 (depends on 15)

The system of claim 15, further including using a coated substrate to deposit binding coated magnetic nanoparticles at an outer surface of the film.

### Claim 20 (depends on 19)

The system of claim 19, including implanting Co ions on epitaxial Au thin films or patterning Co films deposited onto Au films.

### Claim 21 (depends on 1)

The system of claim 1, wherein nanoclusters are formed, and adjusting one or more of the size and the inter-particle distance of the nanoclusters.

### Claim 22 (depends on 1)

The system of claim 1, further including using a solution of coated ferromagnetic nanoparticles to deposit binding nanoparticles of an outer surface of a thin film.

### Claim 23 (depends on 5)

The system of claim 5, wherein the glycoconjugate comprises a carbohydrate molecule or a carbohydrate moiety.

### Claim 24 (depends on 23)

The system of claim 23, further including incorporating a reactive spacer structure moiety into the glycoconjugate, wherein the reactive moiety interact with a surface of the nanoparticle to form the glyco-nanoparticle.

### Claim 25 (depends on 24)

The system of claim 24, wherein the spacer structure comprises a hydrophilic linker.

### Claim 26 (depends on 24)

The system of claim 24, wherein the spacer structure comprises a hydrophobic linker.

### Claim 27 (depends on 5)

The system of claim 5, further including immobilizing one or more glycoconjugates onto the magnetic nanoparticles under reductive conditions.

### Claim 28 (depends on 27)

The system of claim 27, comprising immobilizing one or more glycoconjugates onto the magnetic nanoparticles using one or more carbohydrates with ferrites and/or transition metals.

### Claim 29 (depends on 27)

The system of claim 27, comprising immobilizing one or more glycoconjugates onto the magnetic nanoparticles under reductive conditions using one or more thiolates with metal atoms.

### Claim 30

A system for detecting an analyte capable of binding with one or more carbohydrates or carbohydrate moieties comprising aggregating glyco-nanoparticles through multivalent interactions.

### Claim 31 (depends on 30)

The system of claim 30, wherein the glyco-nanoparticle is magnetic, and further including separating the analyte using a magnet.

### Claim 32 (depends on 30)

The system of claim 30, wherein the analyte comprises one or more of: a protein, an antibody, and, a pathogen including bacteria, protozoa, or viruses.

### Claim 33

A system for detecting magnetic glyco-nanoparticles comprising:
measuring a spectral magneto-optical response (θK vs v) of the glyco-nanoparticles using a magneto-optical effect;
measuring an incident angle in reflection geometry with an alternating magnetic field applied; and,
characterizing the magneto-optical response of the magnetic glyco-nanoparticles in media using a Faraday effect in transmission geometry.

### Claim 34 (depends on 33)

The system of claim 33, including binding one or more media to an outer surface of glyco-nanoparticle, thereby altering surface plasmon behavior.

### Claim 35 (depends on 33)

The system of claim 33, wherein the media comprises a ferrofluid, and the system further comprising measuring magneto-optical relaxation of the ferrofluid formed by the glyco-nanoparticles in suspension.

### Claim 36 (depends on 33)

The system of claim 33, including measuring magnetization relaxation using a magneto-optical effect as modified for transmission geometry.

### Claim 37

A system for detecting the presence of pathogenic cells in a medium believed to contain one or more pathogenic cells, comprising:
mixing magnetic glyco-nanoparticles with the medium, whereby a glyco-nanoparticle-pathogen complex is formed if any pathogenic cells are present in the medium;
separating the glyco-nanoparticle-pathogen complex from the media; and,
measuring a response of the glyco-nanoparticle-pathogen complex.

### Claim 38 (depends on 37)

The system of claim 37, further including a magneto-optical response of the glyco-nanoparticle-pathogen complex.

### Claim 39

A system using a glyco-nanoparticle-pathogen complex as an anti-infectious agent comprising:
mixing magnetic glyco-nanoparticles with at least one medium believed to contain cells of one or more pathogenic agents, whereby the magnetic glyco-nanoparticles attach to cells of the pathogenic agent; and
separating the cells from the medium.

### Claim 40

A system for evaluating one or more of magnetic and magneto-optical characterizations using magneto-optical effect, the system comprising:
a device for measuring reflection geometries using fixed frequency light with variable incidence angle and an alternating magnetic field applied; and,
a device for finding an optimum frequency for observation of a plasmon-enhanced magneto-optical effect using spectral determination of θK in reflection geometry.

### Claim 41 (depends on 40)

The system of claim 40, further including a device configured for detecting Kerr rotation that is enhanced due to plasmon resonance and/or surface plasmon resonance response that is magneto-optically enhanced, wherein the shape angular position and amplitude of the plasmon resonance are affected by one or more of a size and shape of a transition metal inclusion.

### Claim 42

A system for detecting magnetic glyco-nanoparticles comprising:
a device configured for measuring a spectral magneto-optical response (θK vs v) of the glyco-nanoparticles using a magneto optical effect;
a device configured for measuring an incident angle in reflection geometry with an alternating magnetic filed applied; and,
a device configured for characterizing the magneto-optical response of the magnetic glyco-nanoparticles in a medium using a magneto-optical effect to determine transmission geometry.

### Claim 43 (depends on 42)

The system of claim 42, further including a device configured for measuring magneto-optical relaxation of a ferrofluid formed by the glyco-nanoparticles in suspension.

### Claim 44 (depends on 43)

The system of claim 43, further including a device configured for measuring of magnetization relaxation using magneto-optical effect as modified for transmission geometry.

### Claim 45

A system for detecting a presence of pathogenic cells in a medium comprising:
a device configured for mixing magnetic glyco-nanoparticles with the medium whereby a glyco-nanoparticle-pathogen complex is formed if any pathogenic cells are present in the medium;
a device configured for separating the glyco-nanoparticle-pathogen complex from the medium; and,
a device configured for measuring a response of the glyco-nanoparticle-pathogen complex.

### Claim 46

An article using the glyco-nanoparticle-pathogen complex as in any of the preceding claims as an anti-infectious agent comprising:
a device for mixing magnetic glyco-nanoparticles with at least one medium believed to contain cells of one or more pathogenic agents, whereby the magnetic glyco-nanoparticles attach to cells of the pathogenic agent; and,
a device for separating the cells from the medium.

### Claim 47

A magneto-plasmonic material comprising magnetic nanoparticles implanted, patterned or coated on a surface, the magnetic nanoparticles exhibiting modulated surface plasmon resonance properties.

### Claim 48 (depends on 47)

The material of claim 47, wherein the surface is capable of having at least one optical property that can be varied.

### Claim 49 (depends on 47)

The material of claim 47, wherein the surface comprises a noble metal thin film or a dielectric thin film.

### Claim 50 (depends on 4)

The system of claim 4, wherein the array includes Co nanoclusters embedded on a metallic Au thin film matrix.

### Claim 51 (depends on 1)

A computer-readable medium having computer-executable instructions for detecting magnetic particles using the system of claim 1.

### Claim 52

A programmed computer system for detecting magnetic nanoparticles comprising: measuring a magneto-optical enhancement of a plasmon absorption optical response.
